Eid, Assaad A.
Habib, Robert H.
Chehab, Omar
Al Jalbout, Nour
Tamim, Hani
Makki, Maha
El Bejjani, Martine
Lima, Joao
Badr, Kamal F.
Funding for this research was provided by:
Medical Practice Plan of the American University of Beirut Medical Center (AUBMC), and the Dean’s Support Package to the “Vascular Medicine Program” at AUBMC.
Article History
Received: 1 September 2022
Accepted: 12 December 2022
First Online: 13 December 2022
Competing interests
: Authors Badr, Lima, Eid, and Habib have conflict of interest being co-founders and own stock in Teucer Biotech Inc, Delaware USA. Teucer Biotech Inc is a Delaware C-Corportion founded around US Patent 10,801,066 issued on 10/13/2020 for “Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger RNA”. Authors Chehab, Al Jalbout, Tamim, Makki, and El Bejjani have no conflicts of interest.